VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $407,000 | +19.7% | 10,600 | 0.0% | 0.14% | +19.0% |
| Q4 2021 | $340,000 | +9.3% | 10,600 | 0.0% | 0.12% | +3.6% |
| Q3 2021 | $311,000 | -20.1% | 10,600 | -7.5% | 0.11% | -13.8% |
| Q2 2021 | $389,000 | +20.4% | 11,460 | +19.3% | 0.13% | +3.2% |
| Q1 2021 | $323,000 | -17.6% | 9,610 | -11.8% | 0.13% | -29.2% |
| Q4 2020 | $392,000 | -93.8% | 10,890 | -93.2% | 0.18% | -89.7% |
| Q3 2020 | $6,332,000 | +85.8% | 161,290 | +73.0% | 1.74% | -12.4% |
| Q2 2020 | $3,408,000 | +88.6% | 93,220 | +24.0% | 1.98% | +47.8% |
| Q1 2020 | $1,807,000 | +16.7% | 75,180 | +42.2% | 1.34% | +43.5% |
| Q4 2019 | $1,548,000 | -59.9% | 52,860 | -63.2% | 0.93% | -64.1% |
| Q3 2019 | $3,865,000 | – | 143,570 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |